Synthorx Inc.

Dec 12, 2019

SHAREHOLDER ALERT: WeissLaw LLP Investigates Synthorx, Inc.

Nov 09, 2018

Synthorx to Present Preclinical Data for THOR-707, a "Not-Alpha" IL-2 Synthorin, for the Treatment of Solid Tumors at SITC 2018

Oct 11, 2018

Synthorx Appoints Pratik Shah, Ph.D., to its Board of Directors

Aug 16, 2018

Synthorx Appoints Immuno-Oncology Veteran Joseph Leveque, M.D., as Chief Medical Officer

Jul 12, 2018

Synthorx Expands Leadership Team with Three Key Hires

Nov 29, 2017

Scientists at TSRI and Synthorx Create the First Semi-Synthetic Organism to Encode and Translate Expanded Genetic Information into a Novel Protein with Different Non-natural Amino Acids

Nov 27, 2017

Laura Shawver, Ph.D., Appointed CEO of Synthorx

Aug 14, 2017

Synthorx Appoints Marcos Milla, Ph.D. as Senior Vice President of Research